GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **351 - 375** of **4050** in total

« First

‹ Prev

…

11

12

13

14

15

16

17

18

19

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G91537AT	46
IgM	Patient 3	-180	mild	G91537AT	120
IgA	Patient 3	4	mild	G91537AT	556
IgG	Patient 3	11	mild	G91537AT	77
IgG	Patient 3	4	mild	G91537AT	76
IgM	Patient 3	11	mild	G91537AT	327
IgM	Patient 3	4	mild	G91537AT	347
IgA	Patient 4	12	mild	G91537AT	516
IgG	Patient 4	12	mild	G91537AT	198
IgM	Patient 4	12	mild	G91537AT	633
IgA	Patient 1	10	moderate	G91237TK	426
IgA	Patient 1	22	moderate	G91237TK	302
IgA	Patient 1	6	moderate	G91237TK	314
IgG	Patient 1	10	moderate	G91237TK	29
IgG	Patient 1	22	moderate	G91237TK	26
IgM	Patient 1	10	moderate	G91237TK	63
IgM	Patient 1	22	moderate	G91237TK	62
IgA	Patient 2	15	mild	G91237TK	253
IgA	Patient 2	24	mild	G91237TK	291
IgG	Patient 2	15	mild	G91237TK	64
IgG	Patient 2	24	mild	G91237TK	50
IgM	Patient 2	15	mild	G91237TK	74
IgG	Patient 1	6	moderate	G91237TK	27
IgM	Patient 1	6	moderate	G91237TK	59
IgA	Patient 2	3	mild	G91237TK	287